Cargando…

Perspectives for the association between olfactory disturbances and depression in Parkinson’s disease

Detalles Bibliográficos
Autores principales:	Ilkiw, Jessica L., Lima, Marcelo M. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2019
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352594/ https://www.ncbi.nlm.nih.gov/pubmed/30632496 http://dx.doi.org/10.4103/1673-5374.247461

Ejemplares similares

Self-directed learning in veterinary medicine: are the students ready?
por: Chigerwe, Munashe, et al.
Publicado: (2017)

New perspectives in iron chelation therapy for the treatment of Parkinson’s disease
por: Nuñez, Marco T., et al.
Publicado: (2019)

Stem Cell Transplantation for Parkinson’s Disease: Current Challenges and Perspectives
por: Zeng, Xinlin, et al.
Publicado: (2022)

Telemedicine in the Management of Parkinson’s Disease: Achievements, Challenges, and Future Perspectives
por: Cubo, Esther, et al.
Publicado: (2022)

The Association of Olfactory Dysfunction With Depression, Cognition, and Disease Severity in Parkinson's Disease
por: Fang, Ting-Chun, et al.
Publicado: (2021)

Pharmacogenomics in Parkinson’s disease: which perspective for developing a personalized medicine?
por: Ciccacci, Cinzia, et al.
Publicado: (2019)

Response kinetics of olfactory receptor neurons and the implications in olfactory coding
por: Reisert, Johannes, et al.
Publicado: (2011)

Parkinson’s disease-associated melanin steal
por: Hinz, Marty, et al.
Publicado: (2014)

Radial glia interact with primary olfactory axons to regulate development of the olfactory bulb
por: Amaya, Daniel A., et al.
Publicado: (2015)

Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson’s disease
por: Müller-Nedebock, Amica C., et al.
Publicado: (2023)

A biophysical perspective on the unexplored mechanisms driving Parkinson’s disease by amphetamine-like stimulants
por: Ferreira, Carla, et al.
Publicado: (2021)

Alpha-Klotho in Parkinson’s disease: a perspective on experimental evidence and potential clinical implications
por: Grillo, Piergiorgio, et al.
Publicado: (2022)

Sleep disturbances and depression severity in patients with Parkinson's disease
por: Kay, Daniel B., et al.
Publicado: (2018)

Olfactory ensheathing cells for spinal cord repair: crucial differences between subpopulations of the glia
por: Ekberg, Jenny A.K., et al.
Publicado: (2015)

Parkinson’s Disease Etiology: Insights and Associations with Phosphate Toxicity
por: Brown, Ronald B.
Publicado: (2022)

Olfactory proteotyping: towards the enlightenment of the neurodegeneration
por: Fernández-Irigoyen, Joaquín, et al.
Publicado: (2019)

Absence of a synergic nigral proapoptotic effect triggered by REM sleep deprivation in the rotenone model of Parkinson´s disease
por: Kmita, Luana C, et al.
Publicado: (2019)

Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson’s disease: A multicenter cross-sectional study
por: Iijima, Mutsumi, et al.
Publicado: (2021)

Mitochondria in the context of Parkinson's disease
por: Villacé, Patricia, et al.
Publicado: (2017)

A Sensor-Based Perspective in Early-Stage Parkinson’s Disease: Current State and the Need for Machine Learning Processes
por: Krokidis, Marios G., et al.
Publicado: (2022)

Inflammaging: disturbed interplay between autophagy and inflammasomes
por: Salminen, Antero, et al.
Publicado: (2012)

Sleep Disturbances Associated with Parkinson's Disease
por: Suzuki, Keisuke, et al.
Publicado: (2011)

Redefining the hypotheses driving Parkinson’s diseases research
por: Farrow, Sophie L., et al.
Publicado: (2022)

Advance care planning in Parkinson’s disease: ethical challenges and future directions
por: Sokol, Leonard L., et al.
Publicado: (2019)

The paradigm of protein acetylation in Parkinson’s disease
por: Yakhine-Diop, Sokhna M.S., et al.
Publicado: (2019)

Cell Therapies for Parkinson's Disease
por: Irion, Stefan
Publicado: (2019)

Falling upward with Parkinson’s disease
por: Buetow, Stephen A., et al.
Publicado: (2017)

Association between Olfactory Deficit and Motor and Cognitive Function in Parkinson’s Disease
por: Yoo, Han Soo, et al.
Publicado: (2020)

Revisiting the Monoamine Hypothesis of Depression: A New Perspective
por: Goldberg, Joel S, et al.
Publicado: (2014)

An Interdisciplinary Perspective on the Association Between Chronotype and Well-being
por: Bullock, Ben
Publicado: (2019)

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside
por: Sulzer, David, et al.
Publicado: (2020)

Olfactory impairment is related to REM sleep deprivation in rotenone model of Parkinson's disease
por: Aurich, Mariana F., et al.
Publicado: (2017)

Comparative efficacy of surgical approaches to disease modification in Parkinson disease
por: Rahimpour, Shervin, et al.
Publicado: (2022)

Mitochondrial dynamics in Parkinson's disease: a role for α-synuclein?
por: Pozo Devoto, Victorio M., et al.
Publicado: (2017)

Olfactory Loss in Parkinson's Disease
por: Haehner, Antje, et al.
Publicado: (2011)

Genetic Analysis of Pathways to Parkinson Disease
por: Hardy, John
Publicado: (2010)

Parkinson’s disease: carbidopa, nausea, and dyskinesia
por: Hinz, Marty, et al.
Publicado: (2014)

Efficacy of cognitive rehabilitation in Parkinson's disease
por: Díez-Cirarda, María, et al.
Publicado: (2018)

The role of viruses in the pathogenesis of Parkinson’s disease
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2020)

Olfactory dysfunction as a common biomarker for neurodegenerative and neuropsychiatric disorders
por: Slabik, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_icb2m39qt2da9jlj30p2s9qbs6